Efficacy and safety of once-weekly subcutaneous semaglutide in adults with overweight or obesity: systematic review with meta-analysis.

Gilson Pires DornelesEllen AlgeriGerhard LauterbachMarcelo PereiraBrigida Fernandes

Published in: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association (2024)

This up-to-date systematic review highlights that once-weekly semaglutide treatment resulted in clinically important weight loss, becoming a promising adjuvant therapy to treat obesity.

Keyphrases

weight loss
systematic review
bariatric surgery
roux en y gastric bypass
gastric bypass
weight gain
meta analyses
insulin resistance
metabolic syndrome
glycemic control
type diabetes
obese patients
high fat diet induced
randomized controlled trial
physical activity